Page last updated: 2024-08-17

quinoxalines and atrial natriuretic factor

quinoxalines has been researched along with atrial natriuretic factor in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19902 (10.00)18.7374
1990's2 (10.00)18.2507
2000's13 (65.00)29.6817
2010's2 (10.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Faber, JE; Gettes, DR; Gianturco, DP1
Hair, WM; Hughes, AD; Martin, GN; Nielsen, H; Schachter, M; Sever, PS; Thom, SA1
Coste, H; Grondin, P1
Campbell, WB; Drewett, JG; Hanke, CJ; Myers, CR1
Axer, H; Steinbusch, HW; Teunissen, CE1
Diamond, J; Hennan, JK1
Bessard, G; Bréant, D; Caron, F; Corompt, E; Devillier, P1
Gao, Y; Moessinger, A; Raj, JU; Sander, FC; Souici, AC; Tolsa, JF1
Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI; Rosas, R; Torres-López, JE; Vidal-Cantú, GC1
Hobbs, AJ; MacAllister, RJ; Madhani, M; Scotland, RS1
Cho, KW; Cui, X; Jin, JY; Kim, SH; Kim, SM; Kim, SZ; Lee, HS; Wen, JF1
Andersen, CU; Mulvany, MJ; Simonsen, U1
Chan, SL; Chan, SS; Fiscus, RR; Fraser, M; Tsang, BK1
Gutkowska, J; Menaouar, A; Mukaddam-Daher, S1
Ahluwalia, A; Hobbs, AJ; Kemp-Harper, B; Madhani, M; Nobles, M; Panayiotou, CM; Scotland, RS; Sheraz, A; Villar, IC1
Chen, J; Fan, F; Han, L; Wang, S; Wang, X; Xie, X; Yan, J; Zhou, X1
de Vente, J; Diederen, RM; Hendrikse, F; La Heij, EC; Markerink-van Ittersum, M1
Fiscus, RR; Wong, JC1
Kang, YH; Morgan, KG; Shin, HM; Yang, IJ1
Clark, BJ; El-Mallakh, RS; Gao, Y; Hamlyn, JM; Tegin, G1

Other Studies

20 other study(ies) available for quinoxalines and atrial natriuretic factor

ArticleYear
Microvascular effects of atrial natriuretic factor: interaction with alpha 1- and alpha 2-adrenoceptors.
    Circulation research, 1988, Volume: 63, Issue:2

    Topics: Animals; Arterioles; Atrial Natriuretic Factor; Brimonidine Tartrate; Microcirculation; Norepinephrine; Osmolar Concentration; Phenylephrine; Quinoxalines; Vasoconstriction; Vasodilation; Venules

1988
Size and site-dependent heterogeneity of human vascular responses in vitro.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1988, Volume: 6, Issue:4

    Topics: Arteries; Atrial Natriuretic Factor; Azepines; Brimonidine Tartrate; Calcitonin Gene-Related Peptide; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Neuropeptide Y; Neuropeptides; Phenylephrine; Quinoxalines; Vascular Resistance; Vasoactive Intestinal Peptide

1988
Characterization of a novel potent and specific inhibitor of type V phosphodiesterase.
    Biochemical pharmacology, 1995, Nov-09, Volume: 50, Issue:10

    Topics: Allopurinol; Animals; Atrial Natriuretic Factor; Cattle; Cyclic AMP; Cyclic GMP; Imidazoles; Isoenzymes; Muscle, Smooth, Vascular; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Quinoxalines; Rats; Sensitivity and Specificity; Stimulation, Chemical

1995
Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect.
    Endocrinology, 1998, Volume: 139, Issue:10

    Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Bacterial Toxins; Cattle; Cells, Cultured; Cyclic GMP; Enterotoxins; Escherichia coli Proteins; Guanylate Cyclase; Humans; Nitric Oxide; Nitroso Compounds; Oxadiazoles; Pregnenolone; Quinoxalines; Zona Glomerulosa

1998
Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction.
    Brain research. Developmental brain research, 2000, Dec-29, Volume: 125, Issue:1-2

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Astrocytes; Atrial Natriuretic Factor; Brain; Cell Culture Techniques; Cells, Cultured; Cyclic GMP; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Female; Guanylate Cyclase; N-Methylaspartate; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Oxadiazoles; Phosphodiesterase Inhibitors; Pregnancy; Quinoxalines; Rats; Rats, Inbred Lew; Signal Transduction; Vasodilator Agents

2000
Effect of NO donors on protein phosphorylation in intact vascular and nonvascular smooth muscles.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:4

    Topics: Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Myometrium; Nitric Oxide Donors; Nitroprusside; Oxadiazoles; Penicillamine; Phosphoproteins; Phosphorylation; Quinoxalines; Rats; S-Nitroso-N-Acetylpenicillamine; Vas Deferens

2001
Relaxation and modulation of cyclic AMP production in response to atrial natriuretic peptides in guinea pig tracheal smooth muscle.
    European journal of pharmacology, 2001, Nov-02, Volume: 430, Issue:2-3

    Topics: Adenylyl Cyclases; Animals; Apamin; Atrial Natriuretic Factor; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; Guinea Pigs; Histamine; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Natriuretic Peptide, C-Type; Nitroprusside; Oxadiazoles; Peptide Fragments; Peptides; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Quinoxalines; Rolipram; Trachea

2001
Differential responses of newborn pulmonary arteries and veins to atrial and C-type natriuretic peptides.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cyclic GMP; Gene Expression Regulation; Guanylate Cyclase; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Natriuretic Peptide, C-Type; Nitric Oxide; Oxadiazoles; Pulmonary Artery; Pulmonary Veins; Quinoxalines; Receptors, Atrial Natriuretic Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sheep; Transcription, Genetic

2002
Role of the nitric oxide-cyclic GMP-K+ channel pathway in the antinociception induced by atrial natriuretic peptide (ANP) and diclofenac.
    Proceedings of the Western Pharmacology Society, 2002, Volume: 45

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atrial Natriuretic Factor; Charybdotoxin; Cyclic GMP; Diclofenac; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formaldehyde; Glyburide; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Pain Measurement; Potassium Channels; Quinoxalines; Rats; Rats, Wistar; Tolbutamide

2002
Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    British journal of pharmacology, 2003, Volume: 139, Issue:7

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Cyclic GMP; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Guanylate Cyclase; Male; Mesenteric Arteries; Mice; Mice, Inbred Strains; Mice, Knockout; Muscle Relaxation; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitrogen Oxides; Nitroglycerin; Oxadiazoles; Phenylephrine; Polysaccharides; Quinoxalines; Receptors, Atrial Natriuretic Factor; Signal Transduction; Spermine

2003
High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
    Circulation research, 2004, Apr-16, Volume: 94, Issue:7

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Atrial Natriuretic Factor; Biological Transport; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Inhibitors; Guanylate Cyclase; Heart Atria; Milrinone; Molsidomine; Myocardial Contraction; Myocytes, Cardiac; Natriuretic Peptide, C-Type; Nitric Oxide Donors; Oxadiazoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazoles; Pyridines; Quinoxalines; Rabbits; Receptors, Cytoplasmic and Nuclear; Second Messenger Systems; Soluble Guanylyl Cyclase; Stroke Volume

2004
Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats.
    European journal of pharmacology, 2005, Mar-07, Volume: 510, Issue:1-2

    Topics: Acetylcholine; Actins; Animals; Atrial Natriuretic Factor; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Guanylate Cyclase; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Lung; Male; Molsidomine; Muscle, Smooth; Oxadiazoles; Piperazines; Pulmonary Artery; Purines; Quinoxalines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Systole; Vasodilation; Vasodilator Agents

2005
Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
    Oncogene, 2006, Apr-06, Volume: 25, Issue:15

    Topics: Adenoviridae; Apoptosis; Atrial Natriuretic Factor; bcl-2-Associated X Protein; Benzothiazoles; Caspase 3; Caspases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Guanylate Cyclase; Half-Life; Humans; Mutation; Ovarian Neoplasms; Oxadiazoles; Phosphorylation; Proto-Oncogene Proteins c-mdm2; Quinoxalines; RNA, Small Interfering; Serine; Signal Transduction; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein

2006
Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    European journal of pharmacology, 2006, Jul-10, Volume: 541, Issue:1-2

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Bridged Bicyclo Compounds; Brimonidine Tartrate; Clonidine; Coronary Circulation; Drug Synergism; Female; Heart; Heart Rate; Heptanes; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Myocardium; Perfusion; Phenoxybenzamine; Prazosin; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Drug; Yohimbine

2006
Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.
    Cardiovascular research, 2007, Jun-01, Volume: 74, Issue:3

    Topics: Acetylcholine; Animals; Aorta; Atrial Natriuretic Factor; Barium; Biological Factors; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Natriuretic Peptide, C-Type; Oligopeptides; Ouabain; Patch-Clamp Techniques; Potassium Channels; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Potassium-Exchanging ATPase; Spermine; Vasodilation; Vasodilator Agents

2007
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.
    European journal of pharmacology, 2007, Jul-12, Volume: 567, Issue:1-2

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Proliferation; Cell Size; Cells, Cultured; Cyclic GMP; Fibroblasts; Intracellular Space; L-Lactate Dehydrogenase; Male; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes

2007
Two autocrine pathways to regulate cyclic GMP synthesis in cultured human retinal pigment epithelial cells.
    Ophthalmic research, 2008, Volume: 40, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Atrial Natriuretic Factor; Autocrine Communication; Cells, Cultured; Cyclic GMP; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Guanylate Cyclase; Humans; Immunohistochemistry; NADPH Dehydrogenase; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Oxadiazoles; Phosphodiesterase Inhibitors; Pigment Epithelium of Eye; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase

2008
Essential roles of the nitric oxide (no)/cGMP/protein kinase G type-Iα (PKG-Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG-Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells.
    Journal of cellular biochemistry, 2011, Volume: 112, Issue:3

    Topics: Animals; Apoptosis; Atrial Natriuretic Factor; Autocrine Communication; Bone Marrow Cells; Cell Adhesion Molecules; Cell Line; Cell Proliferation; Cell Survival; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mice; Microfilament Proteins; Multipotent Stem Cells; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphoproteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Quinoxalines; RNA Interference; Signal Transduction

2011
Cinnamyl alcohol attenuates vasoconstriction by activation of K⁺ channels via NO-cGMP-protein kinase G pathway and inhibition of Rho-kinase.
    Experimental & molecular medicine, 2012, Dec-31, Volume: 44, Issue:12

    Topics: Animals; Aorta; Atrial Natriuretic Factor; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dipeptides; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Male; Methylene Blue; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Phenylephrine; Phosphorylation; Potassium Channel Blockers; Potassium Channels; Propanols; Quinoxalines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Vasoconstriction; Vasodilation

2012
Inhibition of endogenous ouabain by atrial natriuretic peptide is a guanylyl cyclase independent effect.
    PloS one, 2021, Volume: 16, Issue:11

    Topics: Adrenal Cortex; Atrial Natriuretic Factor; Cell Line, Tumor; Cyclic GMP; Guanylate Cyclase; Humans; Ouabain; Oxadiazoles; Peptide Fragments; Quinoxalines; Radioimmunoassay; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Second Messenger Systems; Vasodilator Agents

2021